ArticleInternal medicine (Tokyo, Japan)2023

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.

Shun Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.